MARIA PETKOVA: Open Payments
NPI 1992284442 · NORTH ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,012 in 193 payments from 19 companies in 2025. Trend: 2023 $868 · 2024 $2,607 · 2025 $4,012
Food & beverage: $3,916Education: $96
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $493 |
| UCB, Inc. | 12 | $469 |
| Incyte Corporation | 22 | $424 |
| Amgen Inc. | 16 | $392 |
| Janssen Biotech, Inc. | 26 | $335 |
| ABBVIE INC. | 18 | $303 |
| Galderma Laboratories, L.P. | 23 | $276 |
| Lilly USA, LLC | 14 | $249 |
| Arcutis Biotherapeutics, Inc. | 17 | $223 |
| Organon LLC | 9 | $213 |
Products named: DUPIXENT, Bimzelx, OPZELURA, OTEZLA, TREMFYA, NEMLUVIO, Zoryve, SKYRIZI.
Industry payments across MA — which companies pay providers there.
